™Your Policy Risk Impact Agent
245 chapters · 1,573 sections in this title.
22 M.R.S. § 2671 Definitions
3.7K chars
As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. [PL 2015, c. 418, §1 (NEW).] 1. Eligible patient. "Eligible patient" means a person who has: A. Received a diagnosis of a terminal illness for which no standard treat…
22 M.R.S. § 2672 Availability of investigational drug, biological product or device by manufacturer
0.6K chars
A manufacturer of an investigational drug, biological product or device may make available the investigational drug, biological product or device to an eligible patient. [PL 2015, c. 418, §1 (NEW).] 1. Compensation. A manufacturer may provide an investigational drug, biological p…
22 M.R.S. § 2673 Action against health care practitioner or health care provider license prohibited
0.8K chars
A licensing board may not revoke, refuse to renew or suspend the license of or take any action against a health care practitioner as defined in Title 24, section 2502, subsection 1-A based solely on the health care practitioner's recommendations to an eligible patient regarding a…
22 M.R.S. § 2674 Officials, employees and agents of the State
0.4K chars
1. Violation. An official, employee or agent of the State may not block or attempt to block an eligible patient's access to an investigational drug, biological product or device. 2. Medical standards of care. This section does not prohibit an official, employee or agent of the St…